MP399 Cell Line

MP399 is a fully characterized myeloma cell line established from a patient with plasma cell leukemia. It has been successfully used to test a drug with anti-myeloma activity in-vitro. Subsequently and based on our preliminary results, a clinical trial involving the use of this drug for myeloma patients was initiated. MP399 can serve as a model to further study the mechanism of action of drugs with anti-myeloma activity.

Duke File (IDF) Number

T-002170

Inventor(s)

  • Gasparetto, Cristina
  • Houser, Lesa
  • Rooney, Barbara

For more information please contact

College

School of Medicine (SOM)